SCHEMBL7245155

SCHEMBL7245155

CCCCOC(=O)OC(C)CCOC(=O)OCC(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.39
FAAH O00519 5/20 0.38
ATM Q13315 1/20 0.37
TSHR P16473 4/20 0.35
HPGD P15428 2/20 0.35
CNR1 P21554 1/20 0.34
CNR2 P34972 1/20 0.34
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
HCAR2 Q8TDS4 1/20 0.33
TDP1 Q9NUW8 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
MEN1 O00255 1/20 0.33
LMNA P02545 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
NFKB1 P19838 1/20 0.33
PTGS1 P23219 1/20 0.33
APEX1 P27695 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14891219 0.89 ALDH1A1 (0.45) ALDH1A1FAAHATMTSHRHPGD
SCHEMBL451401 0.87 ALDH1A1 (0.50) ALDH1A1ATMTSHRHPGDNPC1
SCHEMBL6896321 0.85 FAAH (0.46) ALDH1A1FAAHATMTSHRCNR1
Ammonia Solution, Strong SCHEMBL27742278 0.85 ALDH1A1 (0.48) ALDH1A1ATMTSHRHPGDNPC1
Chloromethane SCHEMBL27516270 0.83 ALDH1A1 (0.47) ALDH1A1ATMTSHRHPGDNPC1
SCHEMBL18856318 0.82 FAAH (0.55) ALDH1A1FAAHCNR1CNR2L3MBTL1
SCHEMBL4419061 0.82 NAAA (0.47) ALDH1A1FAAHTSHRHCAR2LMNA
SCHEMBL6378729 0.82 NAAA (0.47) ALDH1A1FAAHTSHRHCAR2LMNA
SCHEMBL13133067 0.82 NAAA (0.47) ALDH1A1FAAHTSHRHCAR2LMNA
SCHEMBL31731103 0.82 TSHR (0.37) ALDH1A1TSHRSMN1; SMN2HCAR2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030069204-A1 Strain of streptomyces SANKYO COMPANY LIMITED (JP) 2003-04-10 US disclosed
US-5650430-A Radicicol derivatives, their preparation and their anti-tumor activity SANKYO COMPANY, LIMITED (JP) 1997-07-22 US disclosed
US-5597846-A ESTERS OF RADICICOL SANKYO COMPANY, LIMITED (JP) 1997-01-28 US disclosed
WO-1991018905-A1 RADICICOL DERIVATIVES, THEIR PREPARATION AND THEIR ANTI-TUMOR ACTIVITY SANKYO COMPANY LIMITED (JP) 1991-12-12 WO disclosed
EP-0460950-A1 Radicicol derivatives, their preparation and their anti-tumour activity Sankyo Company Limited (JP) 1991-12-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030069204-A1 Strain of streptomyces O60361, CYP8B1, MRPS34 ALDH1A1 858/4885FAAH 357/4885ATM 3801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.